NCT02203812View on ClinicalTrials.gov

Effect of Probiotic Lozenge on Gingivitis and Periodontitis

PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

May 31, 2016

Conditions
Mild and Moderate Chronic Periodontitis
Interventions
DRUG

Probiotic Arm

Each Inersan lozenge contains at least 1 billion colony forming unit of Lactobacillus brevis CD2

DRUG

Placebo Arm

Placebo lozenges contain all ingredients except the active constituent (probiotic, Lactobacillus brevis CD2)

Trial Locations (1)

520004

Department of Periodontology, Government Dental College & Hospital, Vijayawada

All Listed Sponsors
collaborator

Government Dental College and Hospital, Vijayawada, Andra Pradesh, India

UNKNOWN

lead

CD Pharma India Pvt. Ltd.

INDUSTRY

NCT02203812 - Effect of Probiotic Lozenge on Gingivitis and Periodontitis | Biotech Hunter | Biotech Hunter